Background: The impact of the use of drug-eluting stents in percutaneous coronary
intervention (PCI) on cardiac care is still uncertain. We examined the influence of systemic …

Objective To determine whether drug-eluting stent (DES) use varies among Scottish
hospitals, and the extent to which any variations are explained by differences between …

Objectives: To assess the impact of the availability of drug-eluting stents (DES) in April 2002
in Emilia-Romagna (a four-million resident Italian region), on the rate of use of …

Drug-eluting stents: a systematic review and economic evaluation. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Background: Despite receiving identical reimbursement for treating heart disease patients
with bare metal stents (BMS) or drug-eluting coronary stents (DES), cardiologists' use of the …

OBJECTIVE: To determine patterns and outcomes of drug-eluting stents (DES) use in
clinical practice. BACKGROUND: DES are technology associated with superior outcomes …

Background In clinical trials, drug-eluting stents (DES) improve clinical outcomes but are
more expensive than bare-metal stents (BMS). Objective To assess clinical and economic …

BACKGROUND: Because of the expense of drug-eluting stents (DES) and associated
adjuvant therapy, nonclinical, socioeconomic factors may be associated with DES use in …

Several studies with drug-eluting stents (DES) have demonstrated dramatic reductions in
restenosis rates compared with bare metal stents (BMS). Although the clinical benefits of …

Objectives: The aim of this investigation was to assess the incremental cost-effectiveness of
replacing bare metal coronary stents (BMS) with drug-eluting stents (DES) in the Province of …